Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib in hospitalized COVID-19 pneumonia
NCT04469114Phase 3Completed
- Sponsor
- Hospital Israelita Albert Einstein
- Start
- Sep 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tofacitinib oral solution in COVID-19 pneumonia, sponsored by Hospital Israelita Albert Einstein. Started Sep 2020; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04469114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04469114.